Company Profile
Treace Medical Concepts Stock Price, News & Analysis
- Ticker:
- TMCI
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
4.38 USD (-8.37%)
Close
Last updated: August 6, 2026
225M USD
Market cap
Why the stock is moving
The latest monitored company update is “Treace Medical Concepts Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.
Company overview
Bunion and Midfoot Surgery
Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy.
Lapiplasty Platform
The Lapiplasty procedure and associated instrumentation enable surgeons to correct and stabilize the metatarsal in multiple planes. Treace has expanded the platform with implants and tools covering a broader range of bunion presentations. The company sells single-use implants and instruments through a specialized field organization, supported by surgeon training and a growing installed base of reusable surgical equipment.
Future catalysts
Treace is still all about bunion surgery and the related midfoot deformity market. The company keeps the surgical-treatment story focused, which means the real question is whether the product set can keep expanding beyond the initial bunion use case and hold its place in routine foot-and-ankle practice.
Recent news
- 01
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
Source: Treace Medical Concepts
- 02
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
Source: Treace Medical Concepts
- 03
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
Source: Treace Medical Concepts
- 04
Treace to Present at the Sidoti Small Cap Conference
Source: Treace Medical Concepts
- 05
Treace Medical Concepts Reports First Quarter 2026 Financial Results
Source: Treace Medical Concepts
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Treace Medical Concepts (TMCI)?
Treace Medical Concepts (TMCI) most recently closed at 4.38 USD, a -8.37% move versus the previous session.
What is the market cap of Treace Medical Concepts (TMCI)?
Treace Medical Concepts currently has a market capitalization of 225M USD on BioPharmSignal.
What does Treace Medical Concepts do?
Bunion and Midfoot Surgery Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy. Lapiplasty Platform The Lapiplasty procedure and associated instrumentation enable surgeons to correct...
On which exchange is TMCI stock listed?
Treace Medical Concepts (TMCI) is associated with NASDAQ, United States, MedTech.
What is Bunion?
Treace is still all about bunion surgery and the related midfoot deformity market.
Which conditions is Treace Medical Concepts targeting with Bunion?
Treace is still all about bunion surgery and the related midfoot deformity market.
How does Treace Medical Concepts describe recent progress with Bunion?
Treace is still all about bunion surgery and the related midfoot deformity market.
What is Midfoot?
Bunion and Midfoot Surgery Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities.